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Abstract
Fibrosarcoma is a deadly disease in cats and is significantly more often located at classical vaccine injections sites. More rare
forms of spontaneous non-vaccination site (NSV) fibrosarcomas have been described and have been found associated to
genetic alterations. Purpose of this study was to compare the efficacy of adenoviral gene transfer in NVS fibrosarcoma. We
isolated and characterized a NVS fibrosarcoma cell line (Cocca-6A) from a spontaneous fibrosarcoma that occurred in
a domestic calico cat. The feline cells were karyotyped and their chromosome number was counted using a Giemsa staining.
Adenoviral gene transfer was verified by western blot analysis. Flow cytometry assay and Annexin-V were used to study cell-
cycle changes and cell death of transduced cells. Cocca-6A fibrosarcoma cells were morphologically and cytogenetically
characterized. Giemsa block staining of metaphase spreads of the Cocca-6A cells showed deletion of one of the E1
chromosomes, where feline p53 maps. Semi-quantitative PCR demonstrated reduction of p53 genomic DNA in the Cocca-
6A cells. Adenoviral gene transfer determined a remarkable effect on the viability and growth of the Cocca-6A cells
following single transduction with adenoviruses carrying Mda-7/IL-24 or IFN-c or various combination of RB/p105, Ras-DN,
IFN-c, and Mda-7 gene transfer. Therapy for feline fibrosarcomas is often insufficient for long lasting tumor eradication.
More gene transfer studies should be conducted in order to understand if these viral vectors could be applicable regardless
the origin (spontaneous vs. vaccine induced) of feline fibrosarcomas.
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Introduction
Fibrosarcoma represents 6–12% of all feline tumors [1]. It is
a malignant tumor of mesenchymal origin, derived from fibrous
connective tissue with the presence of undifferentiated pro-
liferating fibroblasts in a collagen matrix, which normally develops
in soft tissues. Fibrosarcoma tumors are significantly more often
located at classical vaccine injections sites on cats. An epidemi-
ologic analysis showed correlation between fibrosarcoma and
injection sites for leukosis vaccines [2]. The vaccines generally
associated with this disease to date have been the adjuvanted
rabies and feline leukemia virus vaccines; however, association
with non-adjuvanted vaccines has been occasionally reported [2].
More rare forms of spontaneous fibrosarcoma have been described
and have been found associated to genetic alterations, such as
allelic loss, point mutations and translocations [3,4].
Surgery is the typical therapeutic treatment, followed if needed
by radiotherapy. Despite the effectiveness of this treatment, there
is a high neoplasm recurrence on the primary tumor site [5].
Several studies reported the low efficiency of chemotherapy by
itself [6,7]. Due to poor cure rates with surgery alone, the
additional use of adjuvant radiation therapy and/or chemother-
apy has been under investigation at multiple veterinary cancer
centers for the last few years [8,9]. Recently, it has been
suggested that the use of a tri-modal therapeutic approach
(radical surgery, radiation therapy and chemotherapy) will very
likely be the preferred therapy for this extremely malignant
tumor [9]. Other options that are being explored encompass also
gene therapy and immunostimolatory gene therapy, which
constitute the most promising treatments [5,10]. The efficiency
of proteins able to stimulate immune responses in feline
fibrosarcoma has been reported in few recent scientific reports
[5,10]. Recombinant plasmids coding IL-2, IFN-c, and GM-CSF
have been used in phase-I studies using intratumoral magneto-
fection [11]. Additionally, cats and dogs treated with repeated
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37743local injections of engineered histo-incompatible cells secreting
high levels of human interleukin-2 (hIL-2) to the tumor site
relapse less frequently and survive longer than control animals
treated by surgery and radiotherapy alone [12]. Recently, viral
vectors expressing feline or human IL2, respectively, were
administered to domestic cats and it was shown a 33% reduction




Because the prognosis of such tumors continues to be poor, we have
compared and contrasted the effects of single and combinatorial




24, and Ras-DN. We also studied the effects of conditionally
replication-competent adenovirus (CRCA) overexpressing immu-
nostimolatory proteins such as IFN-c or Mda-7/IL-24 and the
combination of the above viral vectors to identify potential cellular
targets for the treatment of this tumor.
Materials and Methods
Clinical Data
A 10-years old domestic calico female cat presented with
a rapidly growing lesion on the first digit of the right front paw,
which became ulcerated and started bleeding within 3 weeks from
the first observation. The tumor formation was surgically removed
in March 2007 at the Martin’s Veterinarian Clinic in Ashland,
Kentucky and it was histologically diagnosed as a fibrosarcoma
that appeared to be completely excised. No chemo- or radiation-
therapy was given. Tumor recurred within 15-days from the first
operation and appeared to grow at a faster rate, doubling its size in
the matter of one week. The cat was amputated of the diseased
limb and a biopsy of the recurred tumor was collected in a sterile
50-mL tube containing sterile cold isotonic saline solution.
Recurred tumor was sent to a veterinarian pathology laboratory
to reconfirm the histological diagnosis.
Ethics Statement
Animal approval from IACUC was not required in this study.
The procedures performed on the animal were conducted as part
of veterinarian standard of care procedures.
Establishment of the Cocca-6A Cell Line
The tumor specimen was minced and treated with 0.25%
trypsin under aseptic conditions to obtain a single-cell suspension,
which was plated in 96-well dishes and cultured with RPMI-1640
(Hyclone, Waltham, MA) medium supplemented with 5% heat-
inactivated fetal bovine serum (Hyclone, Waltham, MA), 100 lU/
mL penicillin, and 1 mg/mL streptomycin (both from Hyclone,
Waltham, MA). The cells were cultured and amplified in 96-, 24-,
6-well, and then in 10-cm culturing dishes. Cells were detached
from the culturing dishes every three days and reseeded at
a concentration of 7.5610
5 cells/dish. One of the clones (Cocca-
6A) has been serially cultured 135 times from March 2007 to May
2011.
Saturation Densities and Doubling Times
Logarithmically growing cell cultures were trypsinized and
5610
4 cells were plated in triplicate in 12-well plates (Costar, St.
Louis, MO) and cultured in DMEM supplemented with 10% FBS.
Cells were counted every second day by hemacytometer. The
doubling time and saturation densities were calculated from a plot
of cell numbers against time.
Karyotype Analysis
Colchicine was added to logarithmically growing cell cultures,
followed by an incubation for 20 min at 37uC. The cells were
harvested with trypsin and incubated for 12 min at 37uCi n
a hypotonic solution containing 0.9% Sodium Citrate. After
centrifugation, the pellet was fixed in three changes of fresh
methanol-glacial acetic acid (3:1, v/v). The fixed cells were
dropped on pre-chilled (220uC) pre-cleaned glass slides and air-
dried. Chromosome spreads were ‘‘aged’’ at 60uC for 24 hours,
subsequently stained in Giemsa for chromosome counts, and
identification. A minimum of 100 spreads was evaluated for modal
chromosome number.
Cell Lines
The human embryonic kidney cell line HEK-293 was
purchased from ATCC (CRL-1573) and was cultured in D-
MEM supplemented with 10% FBS, L-Glutamine, Penicillin and
Streptomycin all from Invitrogen Life Technologies, USA, in 95%
air and 5% carbon dioxide (CO2) at 37.0uC. Feline Skeletal
Muscle Cells (FSkMC) isolated from the limbal skeletal muscle
were purchased from CellApplication (F-150-05) and were grown
in Feline Skeletal Muscle Cell Growth Medium (F-151-500)
(CellApplication, San Diego, CA) in 95% air and 5% carbon
dioxide (CO2) at 37.0uC.
Semi-quantitative Genomic PCR Analysis
Genomic DNA extraction was conducted as previously de-
scribed on HEK-293, FSkMC, and Cocca-6a cells [13]. Genomic
DNA was treated with RNAse-A before conducting PCR. Primers
for p53 were as follows: p53-F 59-TAC-TCC-CCT-GCC-CTC-
AA-39; p53-R 59-GGA-GTC-TTC-CAG-TGT-GAT-GA-39 [14].
Primers for HPRT were as follows: HPRT-F 59-ACT-GTA-ATG-
ACC-AGT-CAA-CAG-GGG-39; HPRT-R 59-TGT-ATC-CAA-
CAC-TTC-GAG-GAG-TCC-39. PCR reactions were conducted
using the Phusion High-Fidelity DNA polymerase kit (Thermo
Scientific, F-530). Annealing temperature for p53 primers was
60uC, and for HPRT primers was 65uC. The Image-J software
(NIH) was used to quantify the densitometric signal acquired by
a Fotodyne computerized imaging system (Fotodyne, Hartland,
WI).
Cytological Observation
The cells were examined under an inverted Olympus IX70
microscope (Olympus America, Inc. Melville, NY). Fluorescence
images were captured with Sensicam QE camera (Cooke Co.,
Auburn Hills, MI) and managed with the SlideBook 3.0 software
(Intelligent Imaging Innovations Inc., Denver, CO).
Adenoviral Production and Purification
Ad.CMV, Ad.GFP and Ad.p53 viruses were generated using
the AdEasy system (Carlsbad, CA). The Ad.RB/p105 viruses were
provided by Dr. Juan Fueyo (M.D. Anderson Cancer Center, The
University of Texas), the Ad.pTEN by Dr. Chris Kontos (Duke
University, Durham, NC) and the Ad.p18, Ad.p19, Ad.p21
waf-1,
and Ad.p27
kip-1 viruses by Dr. Frank L. Graham (McMaster
University, Hamilton, Ontario Canada). CTV-Mda7 (Ad.PEG-
E1A-mda-7), CTV-IFN-c (Ad.PEG-E1A-IFN-c), and Ad.mda-7/
IL-24 were provided by Dr. Paul Fisher (Virginia Commonwealth
University, Richmond VA). The Ad.Ras-DN (dominant negative
(116Y) v-H-RAS mutant) and Ad.p130 (RBL2/p130) viruses were
purchased from Vector BioLabs (Philadelphia, PA). All the
Adenoviruses were amplified, tittered and purified as previously
described [15,16]. Adenovirus transductions were performed using
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Fetaclone-III heat-inactivated FBS (Hyclone, Thermo Scientific,
Waltham, MA). Combinations of adenoviral transductions were
done using a total of 50 MOI viruses. After 16 h, the media were
replaced with fresh media and cells were collected after 24- or 48-
hours.
Western Blot Analysis
Western blot analysis was conducted essentially as previously
described [15,17]. Equal amounts of protein (50 mg) were
separated electrophoretically on polyacrylamide gels in the
presence of SDS (SDS-PAGE) and blotted onto a nitrocellulose
membrane electrophoretically. Immunodetection was performed
Figure 1. Establishment of a feline fibrosarcoma cell line. (A) Hematoxylin & Eosin staining of the pathologic specimen. Optical microscope
1006 magnification of the neoplastic tissue shows cells that appear to have indistinct cell borders, round to oval nuclei with finely stippled
chromatin, and small single or multiple nucleoli. (B–F) Phase contrast imaging of the Cocca-1A, -2A, -3A, -6A, and -3B clones after 48 hours of culture
(2006 magnification). (G) Phase contrast, 2006 magnification of the clone 6A after 3 months of continuous culture. (H–J) Phase contrast, 2006
magnification of the clone 6A after 6-, 12-, and 24 months of continuous culture.
doi:10.1371/journal.pone.0037743.g001
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IL) according to the manufacturer’s instructions.
The following primary antibodies were used: mouse monoclonal
antibodies against p53 (DO-1) cat#sc-126 (1:500), p18 cat#sc-
9965 (1:100), p19 cat#sc-65594 (1:100), RB/p105 cat#sc-102
(1:250) (Santa Cruz Biotechnology, Santa Cruz, CA), Mda-7/IL-
24 k101 (GenHunter Corporation), b-actin cat#A3853 (1:1,500)
(Sigma Aldrich); mouse polyclonal IFN-c cat#H00003458-801
(Abnova); and rabbit polyclonal antibodies against RBL2/p130
cat#sc-317 (1:250), p21 cat#sc-397 (1:125), p27 cat#sc-528
(1:500), H-Ras cat#sc-520 (1:500) (Santa Cruz Biotechnology,
Santa Cruz, CA), pTEN cat#9552 (1:500) (Cell Signalling) and
GFP cat#632377 (1:500) (BD Bioscience).
Flow Cytometry Assay
Media of growing cells was collected; attached cells were washed
with PBS and trypsinized. Samples were prepared, run by a FACS
Aria (BD Bioscience, San Jose, CA) and analyzed using the flow
cytometry analysis software Flow-Jo (Flow-Jo, Ashland, OR) as
previously described [17].
Annexin-V Assay
Annexin-V was analyzed with the Annexin-V/FITC Kit
(Bender MedSystems, Burlingame, CA) following manufacturer’s
instructions. Cytometry was operated with a FACS Aria (BD
Bioscience, San Jose, CA). Annexin-V assay experiment was
repeated three times and was run as triplicate of technical repeats.
Statistical analysis was performed with IBM SPSS statistic
software.
Statistical Analysis
Statistical analysis was performed using the IBM SPSS statistical
software. Comparison of Sub-G1 (apoptotic fraction) populations
on adenoviral transduced groups and comparison of cell death by
Annexin-V on adenoviral transduced groups were conducted
using an ANOVA test with post hoc test of Dunnett’s T3. p values
of less than 0.05 were considered statistically significant.
Results
Establishment of a Feline Spontaneous Fibrosarcoma
Cell Line
A tumor biopsy was taken from a recurring spontaneous feline
fibrosarcoma, which required the amputation of the entire right
limb. The specimen was sent to the pathologist for histological
determination. The pathology report described the presence of an
irregular dermal-subdermal mass of sheets and streams of spindle
cells and small amounts of collagenous stroma, which is
compatible with a diagnosis of fibrosarcoma (Fig. 1 A). Figure 1A
shows at 1006 enlargement the H&E staining of a histological
cross-section of the feline pathologic specimen. The cells appeared
to have indistinct cell borders, round to oval nuclei with finely
stippled chromatin, and small single or multiple nucleoli. The cells
had a mitotic index of 12/10 high power fields.
The biopsy was minced and dissociated within an hour to
obtain cells for a primary culture. Cells able to attach and survive
showed a typical fibroblast aspect forming various clones of the
feline primary culture (Figs. 1 B–F). The clone Cocca-6A after 3
months of continuous culture started growing rapidly and the cells
appeared homogeneous in size (Fig. 1 G). The morphology of the
Cocca-6A cells remained unchanged after 6, 12 months (Figs. 1 H
and I), still remains unchanged after 2 years and over 200 passages
of continuous culture (Fig. 1 J). The Cocca-6A cells showed
a serum dependent growth and did not form colonies in soft agar
(data not shown). We characterized the growth of the Cocca-6A
cell line and found that at serial passage 135 the cells maintained
a fibroblastic appearance. Additionally, we observed that at
passage one hundred, there was a population doubling time of
approximately 27 hours.
Karyotype Analysis and Semi-quantitative Genomic
DNA PCR
We have analyzed the karyogram of the Cocca-6A cells at early
and late passages (passages 5 and 100). Chromosome counts
showed that the Cocca-6A cells were nearly diploid, with
a chromosome number of 37 (normal cat; 2n=38). Metaphase
cells obtained at passage 100 had the same chromosome numbers
of 37 (Fig. 2A). Chromosomes were paired following a Giemsa
Figure 2. Karyogram of the feline fibrosarcoma Cocca-6A cells. (A) Oil immersion microphotograph (10006magnification) of Giemsa block
stained spotted metaphases from a representative colchicine treatment of the Cocca-6A cells. The Cocca-6A cells show the absence of one of the E1
chromosomes. (B) Semi-quantitative PCR of p53 gene in human HEK-293, feline FSkMC and Cocca 6A cells.
doi:10.1371/journal.pone.0037743.g002
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where, among other genes, the p53 gene product maps in feline
(Fig. 2A). We have also performed a semi-quantitative genomic
DNA PCR using primers against p53, which has been previously
identified on chromosome E1. The p53 primers used amplified
also part of the human p53 (HEK-293 cells) as shown in figure 2B.
The PCR products of genomic p53 amplified from Cocca-6A cells
was less abundant in comparison to the PCR product from the
feline skeletal muscle cells (FSkMC). Results were normalized to
the HPRT control from the X chromosomes, which amplified an
equal amount of PCR product.
Effects of Adenoviral Gene Transfer on Cat Fibrosarcoma
We have studied the effects of the transduction of various
proteins involved in the cell cycle and apoptosis pathways such as
Rb/p105, p130, p53, p18, p19, p21
waf-1, p27
kip-1, pTEN, and the
dominant negative H-RAS Mutant (116Y) (RasDN), as well as of
two immunostimulatory cytokines (Mda-7/IL-24, and IFN-c) that
were transferred and expressed into the feline cells using
adenoviruses. Cocca-6A cells were transduced using a total of 50
MOIs of the various adenoviruses without showing a cytopathic
effect. An adenovirus carrying an empty CMV promoter and
Adenovirus containing the green fluorescence protein (GFP)
(Fig. 3A and B) were used as controls. The cell cycle analysis of
the transduced Cocca-6A cells with 50 MOIs of Ad.GFP (Fig. 3C),
was comparable to the transduced Cocca-6A cells with Ad.CMV
and the untransduced control (data not shown).
Weobserveda trendtoward anincreaseofthesub-G1 fractionof
Cocca-6A cells transduced with Ad.RB/p105 (p=0.257), Ad.Ras-
DN (p=0.135), Ad.Mda7/IL-24 (p=0.243), CTV.mda-7/IL-24




1, or Ad.pTEN (Figs. 4 A–G and Table 1) with p.0.05, when
comparedtothe Ad-CMV(Fig.3Aand Table1)ortoAd-GFPmock
transducedcells(Fig.3BandTable1).Thetransducedcellswiththe
adenovirus carrying the green fluorescence protein (GFP) showed
anormalcellcycleprofile,withasmallfractionofthecellsinsub-G1
phase (2.7%), similar to that of Ad.CMV transduced and to
untransduced cells (Fig. 3 C, Table 1, and data not shown).
Figure 3. Effects on the feline fibrosarcoma Cocca-6A cells following Adenoviral gene transfer. (A) Phase contrast imaging of Ad.CMV
transduced Cocca-6A control cells at 24 hours (2006magnification). (B) Fluorescence imaging (2006magnification) of the Ad.GFP-transduced Cocca-
6A control cells at 24 hours. (C) Flow-cytometric diagram of Ad.GFP transduction of Cocca-6A cells (50 MOI, 24-hours after transduction). (C–H) Phase
contrast imaging (2006magnification) of Ad.Rb/p105, Ad.Ras-DN, Ad.mda7/IL-24, CTV/IFNc, and CTV-mda7/IL-24 transduced Cocca-6A cells (50 MOI,
24-hours after transduction).
doi:10.1371/journal.pone.0037743.g003
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effect on the feline fibrosarcoma cells (see Fig. 4) we decided to test
the combinatorial effects of Ads carrying proteins that elicited
a more profound response (Fig. 5 c–g and see fig. 4). A propidium
iodide-flow cytometry analysis of cells transduced with 50 MOIs of
various combinations of double or triple transductions using Ads
carrying Ad.RB/p105, Ad.Ras-DN, Ad.mda-7/IL24, CTV.mda-7/
IL24 or CTV.IFNc demonstrated a considerable increase of the
apoptotic fraction (Sub-G1) in the various samples examined.
Figure 5 depicts the contrast phase microscope images of the
Cocca-6A cells and the cell cycle profiles following combined
adenoviral transduction treatments, which were analyzed using an
ANOVA (Analysis of Variance) with a post hoc test of Dunnett’s
T3 to compare the Sub-G1 (apoptotic fraction) populations on
several adenoviral transduced groups (Table 1). The following
adenoviral combinations showed an increased amount of Sub-G1
population (Fig. 5h–q): Ad.Rb/p105 and Ad.Ras-DN (Fig. 5h),
Ad.Rb/p105 and Ad.mda7/IL24 (Fig. 5i), Ad.Rb/p105 and
Ad.CTV-Mda-7/IL24 (Fig. 5j), Ad.Rb/p105 and Ad-CTV IFN-c
(Fig. 5k), Ad.Ras-DN and Ad.Mda-7/IL-24 (Fig. 5l), Ad.Ras-DN
and Ad.CTV-Mda-7/IL-24 (Fig. 5m), Ad.Ras-DN and Ad-CTV-
IFN-c (Fig. 5n), Ad.Rb/p105 and Ad.Ras-DN and Ad.Mda-7/
IL24 (Fig. 5o), Ad.Rb/p105 and Ad.Ras-DN and Ad.CTV-Mda-7/
IL24 (Fig. 5p), Ad.Rb/p105 and Ad.Ras-DN and Ad-CTV-IFN-c
(Fig. 5q).
To quantify the apoptotic rate of the transduced cells we
assayed the samples by assessing Annexin-V expression. The
analyzed cells were allocated in a quadrant diagram according to
their DNA content and the presence of Annexin-V on the
extracellular side of the cell membrane during apoptosis. Statistical
analysis was run on Annexin-V triplicates of three separate
experiments using IBM SPSS statistic software for an ANOVA on
dead cells with a post hoc test of Dunnett’s T3 post hoc test (Fig. 6
and Table 2). Cocca-6A cells undergoing apoptosis and necrosis
were collectively called as dead cells. Ad.CMV transduced cells
were compared to mock untransduced cells and no statistically
difference was observed (p=0.585, Table 2). All samples were
compared to the Ad.CMV transduced negative control. Mean and
standard deviation from Annexin-V experiment was calculated for
each adenoviral treated groups. Groups transduced with single
Ad.Mda7, Ad.CTV-Mda7 and Ad.CTV-IFNc or double gene
transfer of Ad.Rb + Ad.Ras DN, Ad.Ras DN + AdCTV.Mda7,
Figure 4. Lack of effects on the feline fibrosarcoma Cocca-6A cells following Adenoviral gene transfer. (A–G) Phase contrast imaging
(2006 magnification) of Ad.p53, Ad.p130, Ad.p18, Ad.p19, Ad.p21, Ad.p27, and Ad.pTEN transduced Cocca-6A cells (50 MOI, 24-hours after
transduction).
doi:10.1371/journal.pone.0037743.g004
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difference against the control (p,0.05, Table 2).
Cocca-6A cells treated with triple combination of Ad.RB,
Ad.Ras DN and Ad.Mda7 gene transfer showed 44.13%63.57
S.D. of dead cells with a p value of 0.006. Triple combination of
Ad.RB, Ad.Ras DN and Ad.CTV-Mda7 showed the highest
percentage of dead cells (51.63%64.30S.D.) with a p value of
0.0001. Amongst the double combinational treatments, Ad.RB
with Ad.Ras DN (44.03%63.37S.D.); and Ad.Ras DN with
Ad.CTV-Mda7 (46%63.18S.D.) showed the highest percentage
of dead cells. Amongst single adenoviral transductions the
Ad.CTV-Mda7 (43.87%66.17S.D.) group had the highest per-
centage of dead cells. Each adenoviral transduction groups showed
high percentage of cell death in comparison to the control
(Table 2).
Feline Skeletal Muscle Cells (FSkMC) isolated from the limbal
skeletal muscle were used to investigate the effects of the various
adenoviral constructs in normal cells. To quantify the apoptotic
rate of the transduced normal cells we assayed the samples by
assessing Annexin-V expression. Statistical analysis was run on
Annexin-V triplicates of three separate experiments using IBM
SPSS statistic software for an ANOVA on dead cells with a post
hoc test of Dunnett’s T3 post hoc test (Fig. S1 and Table S1).
Ad.CMV transduced FSkMC cells were compared to mock
untransduced FSkMC cells and no statistically difference was
observed (Table S1, p.0.05). All samples were compared to the
Ad.CMV transduced negative control. Mean and standard
deviation from Annexin-V experiment was calculated for each
adenoviral treated groups. All groups transduced with any of the
adenoviruses carrying pro-apoptotic or cell cycle genes showed no
statistical significant difference against the Ad.CMV transfected
control (Table S1).
To verify the expression of the transduced adenoviral vectors,
western blot analysis was performed forty-eight hours following
transduction with the various adenoviral vectors. Figure 7 shows
that the various adenoviruses successfully transferred and
expressed the targeted transgene in the Cocca-6A cells. Antibodies
against p21, pRb/p105, p130, and Beta Actin used in the western
blot analysis of the transfected and untransfected Cocca-6A cells
cross-reacted with feline species (control lane).
To verify the feline cross-reactivity of the antibodies, which were
raised against human proteins, we performed a series of western
blot analysis using human HEK-293 cells and Feline Skeletal
Muscle Cells (FSkMC) isolated from the limbal skeletal muscle as
controls (Figure 8). Interestingly, antibodies raised against the
human p21, p53, pRb and p130 proteins cross-reacted with feline
proteins from lysates of normal FSkMC cells. The p53 antibody
(clone DO-1), which has been reported to cross-react with cat p53
[18], did show only a weak band in the Cocca-6A cells compared
to the normal FSkMC cells (Figure 8).
Discussion
Despite aggressive pre- or postoperative treatment, feline
fibrosarcomas have high recurrence rates. Purpose of our work
was to establish a cell line from a recurring spontaneous domestic
cat fibrosarcoma and to test the efficiency of gene transfer for the
treatment of this aggressive cancer given the lack of other
therapeutic options. Spontaneous feline fibrosarcomas are more
rare and have not been associated with a vaccination site [19–22].
A retrospective study of 195 feline sarcomas showed that 170
(87.2%) were fibrosarcomas [23]. In this work it was also noted
that cats with vaccination site (VS) fibrosarcomas were younger
(median =8 years) than cats with non-vaccination site (NVS)
fibrosarcomas (median =11 years), but there was no such
association with breed, sex, or ‘‘neuter status’’ [23]. The cell line
we have established is derived from a spontaneous (NVS)
fibrosarcoma arising on the first digit of the right front limb of
a 10-year old domestic female calico cat. Although feline
fibrosarcoma doesn’t appear to be an infrequent disease, no
established fibrosarcoma cell lines of spontaneous origin are
commercially available causing further difficulties in testing
appropriate and more effective treatments for this disease.
Recently, recombinant human proteins such as Interleukin-2 (h-
IL-2) has been used as a treatment option for cats with
fibrosarcoma [5,12]. It has been shown that feline fibrosarcomas
treated with human IL-2 relapse less frequently and patients
survive longer than control animals treated by surgery and
radiotherapy alone suggesting that gene transfer approach using
human gene products could be a suitable treatment option for this
disease [5,12]. In this work we have tested and compared the
ability of a series of adenoviruses carrying various human proteins
that are involved in regulation of the cell cycle or apoptosis such as
Rb/p105, p130, p53, p18, p19, p21
waf-1, p27
kip-1, pTEN, and the
Table 1. ANOVA (Analysis of Variance) significance table with
a Post Hoc Dunnett’s T3 test for a propidium iodide flow
cytometry analysis of Cocca-6A cells transduced with 50 MOIs
of various single transductions and combinations of double or
triple transductions using Ads carrying Ad.RB/p105, Ad.Ras-
DN, Ad.mda-7/IL24, CTV.mda-7/IL24 or CTV.IFNc.














Ras DN 239.6000000 .135
Ad Mda7 218.6000000 .243
CTV Mda7 215.3666667 .573
CTV IFN-c 218.8333333 .185
RB + Ras DN 221.4666667 .323
RB + Mda7 215.4333333 .634
RB + CTV Mda7 244.4666667 .345
RB + CTV IFN-c 248.5666667* .050
Ras DN + Mda7 214.6666667 .280
Ras DN + CTV Mda7 253.3666667 .057
Ras DN + CTV IFN-c 252.8000000* .011
RB + Ras DN + Mda7 211.1666667 .992
RB + Ras DN + CTV Mda7 263.9333333* .005
RB + Ras DN + CTV IFN-c 262.8666667* .007
*The mean difference is significant at the 0.05 level.
The statistical analysis was run using IBM SPSS software.
doi:10.1371/journal.pone.0037743.t001
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tested the effects of two immunostimolatory human cytokines
(Mda-7/IL-24, and IFN-c) that were transferred and expressed into
the feline fibrosarcoma cells using adenoviruses. Interestingly, no
cell cycle modifications were observed when transducing the feline
fibrosarcoma cells with single transfer of adenoviruses expressing
human p53, p130, p18, p19, p21
waf-1, p27
kip-1, or pTEN
compared to the parental control or to Ad-GFP mock transduced
cells (data not shown). We have not further investigated why
despite successful human protein expression in feline cells as
confirmed by western blot analysis (Fig. 7), a set of cell cycle/
apoptosis regulators have failed to elicit an effect on the growth
and viability of the feline cells. One possible explanation is that the
amino-acid sequences of the human proteins used in the
adenoviral transduction assays could differ so much from the
feline proteins to not be able to elicit an effect on the feline cell
cycle/apoptosis machinery.
In a recent published report, the presence of numerical
chromosomal and centrosomal aberrations in 5 vaccine-associated
feline fibrosarcoma cell lines and in a fetal dermal fibroblast cell
line as a control was determined. It was found that the number of
chromosomes deviated abnormally from the normal feline
chromosome number of 2n =38, ranging from 19 to 155
chromosomes per cell [24]. Interestingly chromosomal counts
showed that the Cocca-6A cells were nearly diploid, with
a chromosome number of 37 (normal cat; 2n =38). Metaphase
cells obtained at passage 100 maintained the same chromosome
numbers (Fig. 2A). Chromosomes were paired following a Giemsa
block staining showing the lack of one of the E1 chromosomes
(Fig. 2A). It has been previously shown that feline tumors are often
associated with mutations in proteins involved in cellular pro-
liferation control. Mutations in the p53 gene have been found
associated with various tumors in people and animals including
fibrosarcomas [14,25–27]. The p53 gene product, that maps on
feline chromosome E1 [28], is a multifunctional transcription
Figure 5. The Effects of the combination of Adenoviral gene transfer on the feline fibrosarcoma cells Cocca-6A. Every panel shows the
phase contrast imaging (2006 magnification, 24-hours post transduction) and the propidium iodide flow cytometry analysis of Cocca-6A cells
transduced with 50 MOIs of various combinations of double or triple transductions using Ads carrying Ad.RB/p105, Ad.Ras-DN, Ad.mda-7/IL24,
CTV.mda-7/IL24 or CTV.IFNc. (a–g) Single adenoviral transduction and controls: (a) Control untransduced Cocca-6A cells. (b) Ad.GFP, (c) Ad.Rb/p105,
(d) Ad.Ras-DN, (e) Ad.Mda7/IL-24, (f) CTV.Mda7/IL-24, (g) CTV.IFNc transduced Cocca-6A cells. (h–q) Combinations of double or triple adenoviral
transductions: (h) Ad.Rb/p105+ Ad.Ras-DN, (i) Ad.Rb/p105+ Ad.Mda7/IL-24, (j) Ad.Rb/p105+ CTV.Mda7/IL-24, (k) Ad.Rb/p105+ CTV.IFNc, (l) Ad.Ras-DN
+ Ad.Mda7/IL-24, (m) Ad.Ras-DN + CTV.Mda7/IL-24, (n) Ad.Ras-DN + CTV.IFNc, (o) Ad.Rb/p105+ Ad.Ras-DN + Ad.mda7/IL-24, (p) Ad.Rb/p105+ Ad.Ras-
DN + CTV.mda7/IL-24, (q) Ad.Rb/p105+ Ad.Ras-DN + Ad.CTV.IFNc transduced Cocca-6A cells.
doi:10.1371/journal.pone.0037743.g005
Figure 6. Apoptotic rate of Cocca-6A cells following Adenoviral gene transfer measured by Annexin-V assay. On the ordinate are
indicated the percentages of dead cells following adenoviral transductions. On the abscissa are indicated the different adenoviruses used. Cells were
stained using an Annexin-V fluorescence kit and were run on a BD scientific Facs-Aria flow cytometer.
doi:10.1371/journal.pone.0037743.g006
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irretrievably damaged DNA, thus preventing propagation of
damaged DNA. More than 50% of tumors in people, including
various sarcomas, have p53 gene mutations. We have shown that
the fibrosarcoma Cocca-6A cells lack one of the E1 chromosomes.
We performed a semi-quantitative genomic DNA PCR on the p53
gene, which is located on the E1 chromosome and have
demonstrated that there is a lower amount of p53 genomic
DNA in the Cocca-6A in comparison to the normal FSkMC cells.
We have tested the ability of an adenovirus carrying human p53
to modulate the cell cycle of these aggressively growing feline
fibrosarcoma cells. Surprisingly, adenoviral mediated overexpres-
sion and gene replacement using human wild-type p53 did not
elicit any effects in the Cocca-6A feline fibrosarcoma cell line. The
lack of cell cycle effects following forced expression of human p53
in the Cocca-6A cells could be due to differences between the
human and feline p53 genes, in fact in has been reported that the
amino-acid sequence of the feline p53 gene is 82.1% and 74.9%
similar to the human and mouse counterparts, respectively [28].
We also tested in Cocca-6A cells the ability to induce cell cycle
arrest of other cell cycle regulators, among which the Retinoblas-
toma protein pRb/p105, p21 (also called waf-1, CIP-1, and SDII)
and p27 (also called Kip-1). The RB/p105 gene has been found
mutated in the majority of human tumors [29,30]. Unfortunately,
there is no data available regarding mutations in the RB/p105
gene in domestic cat tumors. Interestingly, in our experiments, the
expression of human RB/p105 showed relatively high levels of cell
death (although not statistically significant) in the Cocca-6A feline
fibrosarcoma cell line, which was instead refractory to the effects of
p53.
In our quest to find the most effective gene transfer tool we also
tested the effects of adenoviral transduction of a mutant form of
Ras (RAS-DN) in Cocca-6A cells and found that its single
expression caused high levels of cell death in the feline
fibrosarcoma cell line, although not statistically significant. Ras is
a protein of the GTPase family that is involved in signal
transduction, cell growth and apoptosis [31]. It has been also
shown that in regulating apoptosis Ras has many faces. It has both
negative and positive effects depending on the stimulation and cell
type. The responses of cells to Ras signaling depends on the level of
Table 2. ANOVA (Analysis of Variance) significance table with
a Post Hoc Dunnett’s T3 test for Annexin-V assay experiment
of Cocca-6A cells following adenoviral gene transfer.




Control CMV 25.46667 .585
RB 235.16667 .063







RB + Ras DN 238.00000
* .004
RB + Mda7 232.23333 .075
RB + CTV Mda7 226.10000 .099
RB + CTV IFN-c 224.26667 .081
Ras DN + Mda7 234.00000 .055
Ras DN + CTV Mda7 239.96667
* .003
Ras DN + CTV IFN-c 233.33333
* .005
RB + Ras DN + Mda7 238.10000
* .006
RB + Ras DN + CTV Mda7 246.93333
* .000
RB + Ras DN + CTV IFN-c 237.70000 .160
*The mean difference is significant at the 0.05 level.
The statistical analysis was run using IBM SPSS software.
doi:10.1371/journal.pone.0037743.t002
Figure 7. Western blot analysis of Cocca-6A cell lysates following adenoviral transduction. On the left lane are loaded control Cocca-6A
cells. In the lane on right are loaded the transduced Cocca-6A cells. Anti beta-actin was used as a loading control. 50 mg of total lysates were run in
SDS polyacrylamide gels. On the left side are indicated the different adenoviral transductions.
doi:10.1371/journal.pone.0037743.g007
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cycle check points [32]. In fibroblasts in particular, the pathway
downstream of activating Ras has been shown to involve the Raf/
MAP kinase pathway, and to function in a p53 dependent manner,
by increasing the levels of p16
kip-4 and p21
waf-1 [32]. When Cocca-
6A cells were transduced with both Ad.RB and Ad.Ras DN
showed higher levels of cell death in comparison to single
adenoviral transduction, which were found to be statistically
significant (p,0.05).
Among the other genes we transferred to the Cocca-6A cells, we
tested the pro-apoptotic and tumor suppressor properties of Mda-
7/IL-24. The Mda-7, Melanoma differentiation associated gene
7/IL-24, is a secreted cytokine with selective activity against
cancer, with anti-apoptotic and anti-angiogenic ability. Based on
sequence homology, chromosomal localization, and its functional
Figure 8. Western blot analysis of HEK-293, FSkMC and Cocca-6A cell lysates. On the left lane are loaded control human embryonic kidney
HEK-293 cells and the central lane are loaded normal feline muscle skeletal cells. In the lane on right are loaded the Cocca-6A cells. Anti beta-actin
was used as a loading control. 50 mg of total lysates were run in SDS polyacrylamide gels.
doi:10.1371/journal.pone.0037743.g008
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10 family of cytokines and named IL-24 [33–36]. The tumor
suppressing ability of mda-7/IL-24 is now well established and is
independent of the status of other tumor suppressor genes, such as
p53 and Rb, or apoptosis regulating genes, such as bax or caspases,
in tumor cells [37]. Recently, a novel adenoviral vector has been
created in which E1A is controlled by the PEG-3 (progression
elevated-3 gene) promoter, which is a promoter that is active only
in cancer cells, enabling the Adenovirus to replicate selectively in
cancer cells [38–40]. This conditionally replicating Adenovirus is
also called Cancer Terminator Virus (CTV). The CTVs have
been engineered to contain sequences for anti-tumoral proteins
such as Mda-7 or IFN-c.
Transduction of the feline fibrosarcoma cells with the CTVs
elicited the greatest negative effects on cellular viability (p,0.05),
due to cellular combined effects of mda-7 or IFN- c and the lytic
properties of the adenoviral particles. The observed tumor cell
killing effects were stronger when we transduced the feline
fibrosarcoma cells with CTV-Mda7 than with IFN-c, possibly
due to the previously demonstrated Mda-7/IL-24 higher pro-
apoptotic ability [37]. We speculate that for the same reason,
greater cell death was observed when using a pro-apoptotic viral
cocktail (Rb and Ras-DN) jointly to the immunomodulating
cytokine Mda-7/IL-24.
In conclusion, we have established a spontaneous feline
fibrosarcoma cell line and have identified the combinatorial use
of Ad.Ras-DN, Ad.Rb and CTV-Mda7/IL-24 genes as a possible
future adjuvant treatment for this case of feline fibrosarcoma.
However, therapy for aggressive feline fibrosarcomas is often
insufficient for complete and long lasting tumor eradication and
more gene transfer studies involving various established feline
fibrosarcomas should be conducted in order to understand if these
viral vectors (Ras-DN, Rb, Mda7/IL24) could be applicable
regardless of the origin (spontaneous vs. vaccine induced) of feline
fibrosarcomas.
Supporting Information
Figure S1 Apoptotic rate of FSkMC cells following
Adenoviral gene therapy measured by Annexin-V assay.
On the ordinate are indicated the percentages of dead cells
following adenoviral transductions. On the abscissa are indicated
the different adenoviruses used. Cells were stained using an
Annexin-V fluorescence kit and were run on a BD scientific Facs-
Aria flow cytometer.
(TIF)
Table S1 ANOVA (Analysis of Variance) significance
table with a Post Hoc Dunnett’s T3 test for Annexin-V
assay experiment of FSkMC cells following adenoviral
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